Spun out of Inesc Tec under a strategic agreement with Frontier IP, Insignals hopes to commercialise a surgical guidance device for brain implants to treat conditions including Parkinson's.

Commercialisation firm Frontier IP on Tuesday unveiled Insignals Neurotech, a Portugal-based spinout of Portuguese Institute for Systems and Computer Engineering, Technology and Science (Inesc Tec), to develop a surgical guidance system for brain implants.
Frontier IP will own a 33% stake in Insignals Neurotech, the third venture to emerge from its pipeline based on strategic agreements with Portuguese institutions.
The company has been founded with the support of São João University Hospital, a medical research and training…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?